Ginkgo Bioworks Holdings DNA
NYSE DNA
$11.48 -0.28 (-2.38%)
As of: Oct 14, 2026 · 3:10 PM EDT

Ginkgo Bioworks Holdings (DNA) Cash from Discontinued Operations (2025 - 2026)

Updated

Ginkgo Bioworks Holdings' Cash from Discontinued Operations was -$2.1 million in Q2 2026, compared with -$1.7 million a year earlier.

Analysis

Ginkgo Bioworks Holdings (DNA) Cash from Discontinued Operations (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ginkgo Bioworks Holdings' Cash from Discontinued Operations was -$12.82 million through Jun 30, 2026.

  • The Q2 2026 figure marks the lowest quarterly Cash from Discontinued Operations since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Iqvia Holdings 43.58 Bn 35.29 Bn 1.44 Bn -
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn -
3 Charles River Laboratories International 14.53 Bn 13.73 Bn 363.37 Mn -
4 Icon 13.23 Bn 10.34 Bn 479.29 Mn -
5 Fortrea Holdings 2.01 Bn 1.39 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 712.22 Mn -49.86 Mn 18.44 Mn -10.61 Mn
7 Evotec SE 502.55 Mn -1.11 Bn - -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn -
9 MindWalk Holdings 64.01 Mn 27.66 Mn 1.61 Mn -
10 Natural Alternatives International 6.63 Mn -21.45 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.61 Mn
Mar 31, 2026 -253,000.00
Jun 30, 2025 7.11 Mn
Mar 31, 2025 -8.77 Mn
API Access

Ginkgo Bioworks Holdings Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=DNA&period=max&api_key=YOUR_API_KEY